AstraZeneca (AZN) Superinvestor holders
33 of the superinvestors we track hold AstraZeneca (AZN) in their latest 13F filings, $12.5B in total.
Summary
The largest holder is PRIMECAP Management (PRIMECAP Management Co), with $3.4B, 2.0% of the portfolio.
In their latest quarter: 5 opened a new position, 16 added, 11 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| PRIMECAP Management PRIMECAP Management Co |
Trimmed | 18,095,178 | $3.4B | 2.0% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 11,501,748 | $1.9B | 0.5% | Q3 2026 |
| Sarah Ketterer Causeway Capital Management |
Added | 9,357,390 | $1.8B | 19.0% | Q2 2026 |
| Arrowstreet Capital | Added | 5,307,020 | $1.0B | 0.4% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | 5,021,518 | $952M | 0.8% | Q2 2026 |
| Mark Donovan Boston Partners |
Added | 3,177,627 | $597M | 0.5% | Q2 2026 |
| Thornburg Thornburg Investment Management |
Added | 2,891,426 | $541M | 5.2% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Trimmed | 2,429,349 | $461M | 1.1% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 2,165,986 | $351M | 0.4% | Q3 2026 |
| WCM Investment Management | New position | 1,310,660 | $249M | 0.5% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 1,094,593 | $208M | 0.1% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 841,164 | $160M | 0.1% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 711,547 | $135M | 0.2% | Q2 2026 |
| Man Group Man Group plc |
Added | 683,112 | $128M | 0.2% | Q2 2026 |
| Jennison Associates | Added | 666,497 | $126M | 0.1% | Q2 2026 |
| Tom Steyer Farallon Capital Management LLC |
Added | 574,000 | $109M | 0.6% | Q2 2026 |
| Harding Loevner | Added | 442,676 | $80M | 0.8% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 400,938 | $75M | 0.0% | Q2 2026 |
| Artisan Partners | New position | 368,074 | $70M | 0.1% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 329,087 | $62M | 0.0% | Q2 2026 |
| Larry Robbins Glenview Capital Management |
New position | 184,279 | $35M | 0.7% | Q2 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
New position | 179,593 | $34M | 0.1% | Q2 2026 |
| Alger Fred Alger Management |
Trimmed | 138,797 | $26M | 0.1% | Q2 2026 |
| Dodge & Cox | Trimmed | 55,949 | $11M | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 54,111 | $10M | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Trimmed | 47,835 | $9M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
New position | 39,644 | $8M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 20,152 | $4M | 0.1% | Q2 2026 |
| Dan Davidowitz Polen Capital Management |
Trimmed | 18,621 | $4M | 0.0% | Q2 2026 |
| Ken Tropin Graham Capital Management |
Added | 5,983 | $1M | 0.0% | Q2 2026 |
| Murray Stahl Horizon Kinetics LLC |
Trimmed | 5,015 | $950,944 | 0.0% | Q2 2026 |
| First Manhattan First Manhattan Co |
Held | 3,554 | $664,978 | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | 2,007 | $380,567 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 33 |
| Q1 2026 | 29 |
| Q4 2025 | 25 |
| Q3 2025 | 27 |
| Q2 2025 | 27 |
| Q1 2025 | 27 |
| Q4 2024 | 29 |
| Q3 2024 | 27 |
Questions about AstraZeneca
Which superinvestors own AstraZeneca?
33 of the superinvestors we track hold AstraZeneca (AZN) in their latest 13F filings, $12.5B in total. PRIMECAP Management, Ken Fisher, Sarah Ketterer, Arrowstreet Capital, Hersh Cohen, Mark Donovan.
Who is the largest superinvestor holder of AZN?
The largest holder is PRIMECAP Management (PRIMECAP Management Co), with $3.4B, 2.0% of the portfolio.
From AstraZeneca's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.